Search clinical trials for: Ruxolitinib Topical

Total 2657 results

Maruho Co., Ltd.

Unknown

Topical Ionic Contra-Viral Therapy in Actinic Keratosis

Actinic Keratosis

Netherlands
Mansoura University

Completed

Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure

Anal Fissure

Egypt
Cynosure, Inc.

Completed

Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma

Melasma

United States
Assiut University

Not yet recruiting

Excimer Light and Topical Steroid in Treatment of Alopecia Areata

Alopecia Areata
Dr. August Wolff GmbH & Co. KG Arzneimittel
SIT Skin Investigation and Technology Hamburg GmbH

Completed

In-Use Test With a Cosmetic Product to Treat Pruritus

Pruritus

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
SIT Skin Investigation and Technology Hamburg GmbH

Completed

In-Use Test With a Cosmetic Product

Dermatitis, Atopic

Germany
Pfizer

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic

United States
Chang Gung Memorial Hospital
Scientis Pharma SA

Recruiting

Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation

Hyperpigmentation; Postinflammatory

Taiwan
Sol-Gel Technologies, Ltd.

Terminated

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Recurrent Basal Cell Carcinoma

United States
Aclaris Therapeutics, Inc.

Completed

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis

United States
Tu Dan
Incyte Corporation

Recruiting

Ruxolitinib for Cancer Cachexia

Cachexia | Stage IV Non-small Cell Lung Cancer

United States
Medical University of Vienna
Astellas Pharma GmbH

Completed

Pain Thresholds Under High-dose Topical Capsaicin

Pain

Austria
Second Affiliated Hospital, School of Medicine,...
First Affiliated Hospital of Jinan University; First Affiliated Hospital of... and other collaborators

Recruiting

Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Wounds

Evaluate the Efficacy of Cyclical Topical Wound Oxygen Therapy in the Treatment of Chronic Wounds

China
Glia, LLC

Active, not recruiting

Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease

Ocular Graft-versus-host Disease

United States
Avicanna Inc

Completed

Effect of a Facial Cream Containing Cannabidiol and Hemp Oil on Skin Hydration and Acne-prone Skin (Dahlia)

Cosmetic Acne

Colombia
Pfizer

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic

United States
Krystal Biotech, Inc.

Completed

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis Bullosa | DEB - Dystrophic Epidermolysis Bullosa

United States
Cairo University

Completed

Effect Of High-Intensity Focused Ultrasound On Abdominal Skin Laxity Post Sleeve Gastrectomy

Gastrostomy | Skin Laxity

Egypt
Taro Pharmaceuticals USA

Completed

Efficacy Study in Patients With Acne Vulgaris.

Acne Vulgaris
Haus Bioceuticals

Completed

Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic
Maja Kovacevic, MD

Withdrawn

Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Androgenetic Alopecia | Female Pattern Hair Loss

Italy
Indonesia University

Active, not recruiting

Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

Androgenetic Alopecia

Indonesia
PellePharm, Inc.

Completed

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Basal Cell Nevus Syndrome

United States, Spain, Germany, United Kingdom, Italy, France, Belgium, Canada, Denmark, Netherlands
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH) (R-HLH)

Haemophagocytic Lymphohistiocytosis
Incyte Corporation

Completed

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo

Vitiligo

United States, Canada
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
Massachusetts General Hospital

Terminated

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Breast Cancer

United States
Washington University School of Medicine
Incyte Corporation

Recruiting

Ruxolitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Graft Versus Host Disease | Graft Vs Host Disease | Graft-versus-host-disease

United States
Keros Therapeutics, Inc.
IQVIA Biotech

Recruiting

Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis

Myelofibrosis

Australia
St. Petersburg State Pavlov Medical University

Recruiting

Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD (JAK-FMT)

Intestinal GVHD

Russian Federation
Panag Pharma Inc.

Completed

Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee

Pain

Canada
Incyte Corporation

Completed

Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Polycythemia Vera | Thrombocytosis | Myelofibrosis

United States
University of Colorado, Denver
Pfizer

Completed

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

Vitiligo

United States
Lenus Therapeutics, LLC

Terminated

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (CELEB)

Dystrophic Epidermolysis Bullosa | Junctional Epidermolysis Bullosa

United States
Chinese PLA General Hospital

Recruiting

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Peripheral Blood Stem Cell Transplantation

China
Sandoz

Completed

Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat

Sore Throat

Russian Federation
BioPharmX, Inc.

Completed

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Acne Vulgaris

United States
Karo Pharma AB

Completed

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

Onychomycosis

Tunisia
Cosmetique Active International

Completed

Anti-aging Repairing Serum: Efficacy and Tolerability Study

Anti-aging

Brazil
Hanyang University
Korean Ministry of Food and Drug Safety; College of Pharmacy, Seoul National...

Completed

Observational Study to Assess Safety and Utility Pattern of Topical Steroids

Skin Diseases

Korea, Republic of
Radboud University Medical Center

Unknown

Efficacy of Topical Coal Tar in Children With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Johnson & Johnson Healthcare Products Division...
Johnson & Johnson Consumer and Personal Products Worldwide

Completed

Clinical Trial in Females for Female Pattern Hair Loss

Androgenetic Alopecia

United States, United Kingdom, France, Germany
Vidac Pharma

Completed

Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
GlaxoSmithKline

Withdrawn

Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol

Skin Irritation
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions

Healthy
Memorial University of Newfoundland

Recruiting

Biofreeze and the Effect on Knee Osteoarthritis

Knee Osteoarthritis

Canada
University Hospital, Essen

Completed

Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients (TECAIN)

Anal Intraepithelial Neoplasia (AIN) in HIV-infected Patients

Germany
BioGaia AB

Completed

Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis

Atopic Dermatitis

South Africa
Instituto Ecuatoriano de Enfermedades Digestivas

Completed

Minimal Injuries From Esophagus Detected by Optical Enhancement System™ Associated to Optical Magnification HD Scopes

GERD | Non Erosive Reflux Disease

Ecuador
Incyte Corporation

Terminated

Study of Ruxolitinib in Colorectal Cancer Patients

CRC (Colorectal Cancer)

United States, France, United Kingdom, Spain, Israel, Australia, Germany, Korea, Democratic People's Republic of

3

Subscribe